Company representatives met with officials in early May and by month's end, the FDA was planning to...
Exclusive | How Replimune’s Drug Got Third Chance After White House Intervention
Company representatives met with officials in early May and by month's end, the FDA was planning to review the melanoma medication again.
Author: WSJ
Read Original Article